These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32085423)

  • 21. Pyrazolopyridines as potent PDE4B inhibitors: 5-heterocycle SAR.
    Mitchell CJ; Ballantine SP; Coe DM; Cook CM; Delves CJ; Dowle MD; Edlin CD; Hamblin JN; Holman S; Johnson MR; Jones PS; Keeling SE; Kranz M; Lindvall M; Lucas FS; Neu M; Solanke YE; Somers DO; Trivedi NA; Wiseman JO
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5803-6. PubMed ID: 20732811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CuCl
    Thirupataiah B; Mounika G; Sujeevan Reddy G; Sandeep Kumar J; Kapavarapu R; Medishetti R; Mudgal J; Mathew JE; Shenoy GG; Mallikarjuna Rao C; Chatti K; V L Parsa K; Pal M
    Bioorg Chem; 2021 Oct; 115():105265. PubMed ID: 34426160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insights into the Pharmacological Activity of the Imidazo-Pyrazole Scaffold.
    Spallarossa A; Rapetti F; Signorello MG; Rosano C; Iervasi E; Ponassi M; Brullo C
    ChemMedChem; 2023 Sep; 18(17):e202300252. PubMed ID: 37366115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of highly potent phosphodiesterase 4 inhibitors with anti-neuroinflammation potential: Design, synthesis, and structure-activity relationship study of catecholamides bearing aromatic rings.
    Zhou ZZ; Ge BC; Zhong QP; Huang C; Cheng YF; Yang XM; Wang HT; Xu JP
    Eur J Med Chem; 2016 Nov; 124():372-379. PubMed ID: 27597413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis, characterization and biological evaluation of novel pyrazole integrated benzophenones.
    Bandgar BP; Chavan HV; Adsul LK; Thakare VN; Shringare SN; Shaikh R; Gacche RN
    Bioorg Med Chem Lett; 2013 Feb; 23(3):912-6. PubMed ID: 23290048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and biological evaluation of pyridazinone derivatives as potential anti-inflammatory agents.
    Barberot C; Moniot A; Allart-Simon I; Malleret L; Yegorova T; Laronze-Cochard M; Bentaher A; Médebielle M; Bouillon JP; Hénon E; Sapi J; Velard F; Gérard S
    Eur J Med Chem; 2018 Feb; 146():139-146. PubMed ID: 29407945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphodiesterase inhibitors. Part 5: hybrid PDE3/4 inhibitors as dual bronchorelaxant/anti-inflammatory agents for inhaled administration.
    Ochiai K; Takita S; Kojima A; Eiraku T; Iwase K; Kishi T; Ohinata A; Yageta Y; Yasue T; Adams DR; Kohno Y
    Bioorg Med Chem Lett; 2013 Jan; 23(1):375-81. PubMed ID: 23200255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design and Synthesis of Novel Pyrazole-Substituted Different Nitrogenous Heterocyclic Ring Systems as Potential Anti-Inflammatory Agents.
    Nossier ES; Fahmy HH; Khalifa NM; El-Eraky WI; Baset MA
    Molecules; 2017 Mar; 22(4):. PubMed ID: 28338602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phosphodiesterase inhibitors. Part 2: design, synthesis, and structure-activity relationships of dual PDE3/4-inhibitory pyrazolo[1,5-a]pyridines with anti-inflammatory and bronchodilatory activity.
    Ochiai K; Ando N; Iwase K; Kishi T; Fukuchi K; Ohinata A; Zushi H; Yasue T; Adams DR; Kohno Y
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5451-6. PubMed ID: 21764304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphodiesterase inhibitors. Part 6: design, synthesis, and structure-activity relationships of PDE4-inhibitory pyrazolo[1,5-a]pyridines with anti-inflammatory activity.
    Kojima A; Takita S; Sumiya T; Ochiai K; Iwase K; Kishi T; Ohinata A; Yageta Y; Yasue T; Kohno Y
    Bioorg Med Chem Lett; 2013 Oct; 23(19):5311-6. PubMed ID: 23988356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pyrazole derivatives as potent inhibitors of c-Jun N-terminal kinase: synthesis and SAR studies.
    Doma A; Kulkarni R; Palakodety R; Sastry GN; Sridhara J; Garlapati A
    Bioorg Med Chem; 2014 Nov; 22(21):6209-19. PubMed ID: 25261929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of neutrophil O(2)(-) production by unsymmetrical methylene derivatives of benzopyrans: their use as potential antiinflammatory agents.
    Mazzei M; Dondero R; Sottofattori E; Melloni E; Minafra R
    Eur J Med Chem; 2001; 36(11-12):851-61. PubMed ID: 11755228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Construction of a six-membered fused N-heterocyclic ring via a new 3-component reaction: synthesis of (pyrazolo)pyrimidines/pyridines.
    Kumar PM; Kumar KS; Mohakhud PK; Mukkanti K; Kapavarapu R; Parsa KV; Pal M
    Chem Commun (Camb); 2012 Jan; 48(3):431-3. PubMed ID: 22075973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel anti-inflammatory agents based on pyrazole based dimeric compounds; design, synthesis, docking and in vivo activity.
    Tewari AK; Srivastava P; Singh VP; Singh A; Goel RK; Mohan CG
    Chem Pharm Bull (Tokyo); 2010 May; 58(5):634-8. PubMed ID: 20460788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of phosphodiesterase 4B in IL-8/LTB4-induced human neutrophil chemotaxis evaluated with a phosphodiesterase 4B inhibitor.
    Suzuki O; Goto T; Yoshino T; Nakamura S; Maeda H
    Acta Pharm; 2015 Jun; 65(2):191-7. PubMed ID: 26011935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and anti-inflammatory evaluation of new 1,3,5-triaryl-4,5-dihydro-1H-pyrazole derivatives possessing an aminosulphonyl pharmacophore.
    Abdellatif KR; Abdelgawad MA; Elshemy HA; Alsayed SS; Kamel G
    Arch Pharm Res; 2015 Nov; 38(11):1932-42. PubMed ID: 25904239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stereoselective synthesis of novel pyrazole derivatives using tert-butansulfonamide as a chiral auxiliary.
    Park CM; Jeon DJ
    Org Biomol Chem; 2012 Apr; 10(13):2613-20. PubMed ID: 22371117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis of Asymmetric 1-Thiocarbamoyl Pyrazoles as Potent Anti- Colon Cancer, Antioxidant and Anti-Inflammatory Agent.
    Raut DG; Patil SB; Kadu VD; Hublikar MG; Bhosale RB
    Anticancer Agents Med Chem; 2018; 18(15):2117-2123. PubMed ID: 30417799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of novel 3,5-diaryl pyrazole derivatives using combinatorial chemistry as inhibitors of tyrosinase as well as potent anticancer, anti-inflammatory agents.
    Bandgar BP; Totre JV; Gawande SS; Khobragade CN; Warangkar SC; Kadam PD
    Bioorg Med Chem; 2010 Aug; 18(16):6149-55. PubMed ID: 20638287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diastereoselective synthesis and profiling of bicyclic imidazolidinone derivatives bearing a difluoromethylated catechol unit as potent phosphodiesterase 4 inhibitors.
    Dorokhov VS; Golovanov IS; Tartakovsky VA; Sukhorukov AY; Ioffe SL
    Org Biomol Chem; 2018 Oct; 16(38):6900-6908. PubMed ID: 30024008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.